111 related articles for article (PubMed ID: 25633515)
1. Diagnostic value of 18F-FDG-PET/CT for monitoring myelofibrosis after allogeneic stem cell transplantation.
Derlin T; Büsche G; Kröger N
Nucl Med Rev Cent East Eur; 2015; 18(1):35-6. PubMed ID: 25633515
[TBL] [Abstract][Full Text] [Related]
2. Serial 18F-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for Myelofibrosis.
Derlin T; Alchalby H; Bannas P; Laqmani A; Ayuk F; Triviai I; Kreipe HH; Bengel FM; Kröger N
J Nucl Med; 2016 Oct; 57(10):1556-1559. PubMed ID: 27230931
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT for detection of leukemic transformation in myelofibrosis.
Derlin T; Clauditz TS; Kröger N
Clin Nucl Med; 2015 Jun; 40(6):521-2. PubMed ID: 25674874
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.
Derlin T; Alchalby H; Bannas P; Veldhoen S; Apostolova I; Triviai I; Bengel FM; Kröger N
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):696-705. PubMed ID: 25601337
[TBL] [Abstract][Full Text] [Related]
5. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
[TBL] [Abstract][Full Text] [Related]
6. Myelofibrosis on 18F-FDG-PET/CT in a case suspicious for post-transplant lymphoproliferative disorder.
Khanna V; Nama S; Tailor R; Muthukrishnan A
Hell J Nucl Med; 2009; 12(3):274-5. PubMed ID: 19936343
[TBL] [Abstract][Full Text] [Related]
7. "Cold" Spondylodiscitis on 18F-FDG PET/CT in a Patient With Myelofibrosis.
Rousseau E; Keu KV
Clin Nucl Med; 2016 Mar; 41(3):e156-8. PubMed ID: 26571440
[TBL] [Abstract][Full Text] [Related]
8. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
9. Extramedullary gastric relapse of acute lymphoblastic leukemia following allogeneic stem cell transplant: staging with F-18 FDG PET/CT.
Ciarallo A; Makis W; Novales-Diaz JA; Michel RP
Clin Nucl Med; 2011 Aug; 36(8):e90-2. PubMed ID: 21716008
[TBL] [Abstract][Full Text] [Related]
10. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation.
Derlin T; Weber C; Habermann CR; Herrmann J; Wisotzki C; Ayuk F; Wolschke C; Klutmann S; Kröger N
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):493-500. PubMed ID: 22113619
[TBL] [Abstract][Full Text] [Related]
13. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT for staging and detection of extramedullary organ involvement in chronic myelomonocytic leukemia.
Derlin T; Clauditz TS; Bannas P
Clin Nucl Med; 2014 Sep; 39(9):811-2. PubMed ID: 24152630
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography - computed tomography as a monitoring response tool in pre-fibrotic myelofibrosis: A case report.
Qamar Uz Zaman A; Hussain S; Zaheer R; Andleeb M; Raza S; Siddiqui T
J Pak Med Assoc; 2022 Mar; 72(3):564-566. PubMed ID: 35320247
[TBL] [Abstract][Full Text] [Related]
17. Myelofibrosis on F-18 FDG PET Imaging.
Burrell SC; Fischman AJ
Clin Nucl Med; 2005 Oct; 30(10):674. PubMed ID: 16166839
[TBL] [Abstract][Full Text] [Related]
18. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Kumar R; Xiu Y; Zhuang HM; Alavi A
Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
[TBL] [Abstract][Full Text] [Related]
20. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C
Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
